Compound index

Growth Hormone Secretagogues & GHRH Analogs

CJC-1295

Also known as CJC-1295 with DAC

Early human trialsInvestigational

Last reviewed: 2026-11-19

Class & structure

A 29-amino-acid chain.

Conceptual amino-acid chain · 29 residues in this molecule

How it’s thought to work

Activates pituitary GHRH receptors; the DAC modification prolongs molecular exposure.

Molecule → target. A conceptual fit, not proof of a clinical effect.

Key sources

Identity and editorial screen completed November 19, 2026. Previously checked primary references retained; this is not an exhaustive clinical review.

Related compounds

  • Examorelin

    Same scientific class · A 6-amino-acid chain. · Early human trials

  • Ipamorelin

    Same scientific class · A 5-amino-acid chain. · Early human trials

  • Modified GRF (1–29)

    Same target family · A 29-amino-acid chain. · Cell/lab studies only

  • Pralmorelin

    Same scientific class · A 6-amino-acid chain. · Early human trials

  • Sermorelin

    Same target family · A 29-amino-acid chain. · Late-stage human trials

Related glossary terms